Monika Tandon

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Zarir Udwadia, Pawan Singh, Hanmant Barkate et al. · International Journal of Infectious Diseases · 2020 · 291 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function

Ramanathan Balamurugan, Monika Tandon, Neelufar Mozaffarian et al. · Pain · 2021 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial

Mala Dharmalingam, S. R. Aravind, Hemant Thacker et al. · Drugs · 2020 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial

Monika Tandon, Wen Wu, Keith Moore et al. · The Lancet Regional Health - Southeast Asia · 2022 · 36 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects

Anju Agrawal, Monika Tandon, P. L. Sharma · International Journal of Clinical Practice · 2007 · 32 citations

Life Sciences, Pharmacology, Pharmacotherapy +17